Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth
- 19 September 2007
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 29 (2) , 278-292
- https://doi.org/10.1016/j.nbd.2007.09.002
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006
- Temporal Control of Rac in Schwann Cell–Axon Interaction Is Disrupted inNF2-Mutant Schwannoma CellsJournal of Neuroscience, 2006
- Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membraneThe Journal of cell biology, 2005
- Senescence in premalignant tumoursNature, 2005
- The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 ExpressionMolecular and Cellular Biology, 2005
- Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouseGenes & Development, 2002
- The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma CellsMolecular and Cellular Biology, 2002
- Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cellsOncogene, 1998
- Isolation and Characterization of Schwann Cells from Neurofibromatosis Type 2 PatientsNeurobiology of Disease, 1998
- Cytokeratin provides a specific marker for human arachnoid cells grown in vitroExperimental Cell Research, 1983